Clinical Trials Directory

Trials / Completed

CompletedNCT05292170

Influences of Female Sex and Reproductive Hormones on Physiological Aspects of Heat Acclimation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
United States Army Research Institute of Environmental Medicine · Federal
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Women are often understudied in thermal physiology research, leaving recommendations for Soldier safety and performance in hot conditions based largely on data collected in men. Female sex hormones estradiol and progesterone clearly have non-reproductive physiological effects, including influences on thermoregulatory and cardiovascular function. However, mechanisms of differing physiological adaptations to repeated heat exposure (i.e., heat acclimation) as a function of reproductive hormone status have yet to be investigated in a systematic way. Understanding possible sex differences in adaptation or mechanisms for adaptation during heat acclimation is important to ultimately optimize interventions to maximize soldier health and safety during training and deployment in the heat. Our goals in the present study are to evaluate physiological and biophysical responses to a standard heat acclimation protocol in a group of young, healthy men and women. Thirty individuals (n=10 males, n=10 women with a low hormonal status (i.e. early follicular phase), n=10 women with a high hormonal status (i.e. midluteal phase)) will complete 10 consecutive days of exercise (treadmill walking: 3.1 mph/2% grade) in the heat (40°C /40% relative humidity) up to 3hr per day. Changes in core temperature, heart rate, and sex hormones will be assessed to examine differences in thermoregulatory response to heat acclimation.

Conditions

Interventions

TypeNameDescription
OTHERHeat acclimation10 consecutive days of heat acclimation

Timeline

Start date
2021-10-01
Primary completion
2024-04-30
Completion
2024-04-30
First posted
2022-03-23
Last updated
2024-08-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05292170. Inclusion in this directory is not an endorsement.